Interferon beta is a naturally occurring protein involved in the body's immune response.
Originally developed to treat asthma and chronic obstructive pulmonary disorder, it's also been used to treat multiple sclerosis for years.
Now, preliminary findings of a Phase 1 clinical trial from the UK claims interferon beta can help patients hospitalized with the novel coronavirus COVID-19.